BillionToOne, Inc. (NASDAQ: BLLN)

Sector: Healthcare Industry: Diagnostics & Research CIK: 0002070849
P/B -4.30
P/E -24.75
P/S 6.74
Market Cap 1.03 Bn
ROIC (Qtr) 0.00
Div Yield % 0.00
Rev 1y % (Qtr) 117.40
Total Debt (Qtr) 108.14 Mn
Debt/Equity (Qtr) -0.45

About

Stock Price Chart

Analysis

Pros

  • Healthy cash reserves of 195.15M provide 34.56x coverage of short-term debt 5.65M, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 327.52M provides 3.03x coverage of total debt 108.14M, indicating robust asset backing and low credit risk.
  • Tangible assets of 327.52M provide exceptional 122.07x coverage of deferred revenue 2.68M, showing strong service capability backing.
  • Tangible assets of 327.52M provide robust 11.98x coverage of other current liabilities 27.33M, indicating strong asset backing.
  • Retained earnings of (280.72M) represent substantial 1.17x of equity (239.51M), indicating strong internal capital generation.

Cons

  • Operating cash flow of 0 provides insufficient coverage of deferred revenue obligations of 2.68M, which is 0x, raising concerns about future service delivery capabilities.
  • Tangible assets of 327.52M provide limited backing for working capital of 210.93M, which is 1.55x, suggesting increased operational risk in market downturns.
  • Other non-current assets of 9.11M provide minimal coverage for long-term debt of 102.49M, which is 0.09x, indicating potential asset-liability mismatch.

Peer Comparison

Companies in the Diagnostics & Research
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 216.83 Bn 33.00 4.96 35.68 Bn
2 DHR Danaher Corp /De/ 162.47 Bn 46.38 6.69 16.86 Bn
3 IDXX Idexx Laboratories Inc /De 56.88 Bn 55.36 13.65 1.09 Bn
4 A Agilent Technologies, Inc. 39.82 Bn 32.64 5.87 3.41 Bn
5 IQV Iqvia Holdings Inc. 38.85 Bn 30.28 2.44 15.19 Bn
6 NTRA Natera, Inc. 31.32 Bn -101.29 14.80 0.18 Bn
7 MTD Mettler Toledo International Inc/ 28.99 Bn 34.68 7.35 2.21 Bn
8 WAT Waters Corp /De/ 22.92 Bn 35.32 7.38 1.49 Bn

Industry Comparisons

Current Valuation

Metric Value Industry Percentile
EV to Assets 0.00 2.69
EV to Cash from Ops. 0.00 18.14
EV to Debt 0.00 52.51
EV to EBIT 0.00 19.22
EV to EBITDA 0.00 4.35
EV to Free Cash Flow [EV/FCF] 0.00 2.84
EV to Market Cap 0.00 1.52
EV to Revenue 0.00 4.79
Price to Book Value [P/B] -4.30 1.34
Price to Earnings [P/E] -24.75 22.02

Dividend Metrics

Metric Value Industry Percentile
Dividend Coverage Ratio 0.00 -1.96
Dividend Payout Ratio % 0.00 2.83
Dividend per Basic Share 0.00 0.19
FCF Dividend Payout Ratio % 0.00 1.92
Interest Coverage 0.00 -126.58

Growth Metrics

Metric Value Industry Percentile
Capex Growth (1y) % 0.00 -31.50
Cash and Equivalents Growth (1y) % 0.00 21.37
Dividend Growth (1y) % 0.00 0.24
EBIAT Growth (1y) % 0.00 -55.24
EBITDA Growth (1y) % 0.00 -447.96
EBIT Growth (1y) % 0.00 -40.50
EBT Growth (1y) % 0.00 -70.94
EPS Growth (1y) % 0.00 -70.02
FCF Growth (1y) % 0.00 56.33
Gross Profit Growth (1y) % 0.00 185.11

Liquidity Ratios

Metric Value Industry Percentile
Asset Utilization Ratio 0.00 0.56
Cash Payout Ratio 0.00 0.01
Cash Ratio 4.78 1.21
Current Ratio 6.17 2.64
Debt to Equity Ratio -0.45 -0.80
Interest Cover Ratio 0.00 -126.58
Times Interest Earned 0.00 -126.58

Profitability

Metric Value Industry Percentile
EBITDA Margin % 0.00 -129.91
EBIT Margin % 0.00 -156.71
EBT Margin % 0.00 -162.23
Gross Margin % 0.00 47.70
Net Profit Margin % 0.00 -189.30